GSK Study Register and patient level data

Sharing our clinical trial results, whether they reflect positively or negatively on our medicines, is the right thing to do.

Sharing our research

Sharing our research. It’s essential to advance scientific understanding, help ensure the medical community and patients have access to the latest information to make decisions about healthcare, and build trust. It is one of the ways we acknowledge the contribution made by those who take part in our clinical research. Patients volunteer on the understanding that they might further the insight into a disease and its treatment through their contribution.

Read about our clinical research transparency policy

hand-clipboard-trials

Our Study Register

The GSK Study Register provides information on our studies. This supplements information presented in scientific journals, at scientific congresses, in letters to healthcare professionals, and in approved prescribing information. We aim to publish our clinical research of our investigational products as papers in the scientific literature.

We believe that all those involved in the conduct and publication of clinical research...have a role to play in ensuring that information from clinical trials is made publicly available.

science research woman.

Patient-level data

We believe that all those involved in the conduct and publication of clinical research, be they companies like GSK, academic institutions or research organisations, have a role to play in ensuring that information from clinical trials is made publicly available. We also recognise that there is a highly detailed level of data sitting behind the published results of our clinical trials that scientific researchers may find useful. This is known as patient-level data. In May 2013 we launched a web-based system for researchers from the scientific community to request access to the anonymised patient-level data from our studies.

We were the first company to develop a system for sharing detailed clinical data in this way, by enabling researchers to examine the detailed data behind our trials more closely and do their own analyses Following the launch of that system, we worked with other trial sponsors to re-configure it into a broader version, enabling researchers to request access to data from multiple study sponsors, not just GSK. The system launched in January 2014 and is now used by a number of sponsors and academic funders.